Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.
about
Head and neck presentations of acquired immunodeficiency syndrome.Impairment of natural killer cell activity in Indian kala-azar: restoration of activity by interleukin 2 but not by alpha or gamma interferon.Loss of NK stimulatory capacity by plasmacytoid and monocyte-derived DC but not myeloid DC in HIV-1 infected patients.Cytokines and their receptors in cardiovascular diseases--role of gp130 signalling pathway in cardiac myocyte growth and maintenance.Accessory cell dependent NK cell mediated PBMC IFN-gamma production is defective in HIV infection.The retinal lesions of the acquired immune deficiency syndromeGastrointestinal manifestations of the acquired immunodeficiency syndrome.Mucosal immunity in the female genital tract, HIV/AIDSDecreased population of Leu-7+ natural killer cells in lymph nodes of homosexual men with AIDS-related persistent lymphadenopathy.The acquired immunodeficiency syndrome (AIDS)Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in humProduction of and in vitro response to interleukin 2 in the acquired immunodeficiency syndromeDefective postbinding lysis underlies the impaired natural killer activity in factor VIII-treated, human T lymphotropic virus type III seropositive hemophiliacsDetection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical stagingNatural killer cells are present in the normal human lung but are functionally impotent.Antiviral activity of mismatched double-stranded RNA against human immunodeficiency virus in vitro.Decreased expression of human class II antigens on monocytes from patients with acquired immune deficiency syndrome. Increased expression with interferon-gamma.Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis.Partial restoration of impaired interleukin-2 production and Tac antigen (putative interleukin-2 receptor) expression in patients with acquired immune deficiency syndrome by isoprinosine treatment in vitro.Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes.Cytokine therapy or structured treatment interruptions in HIV infection: which is best?Loss of the perforin cytotoxic pathway predisposes mice to experimental cytomegalovirus retinitis.Effects of cytokines on antiviral pharmacokinetics: an alternative approach to assessment of drug interactions using bioequivalence guidelines.Determination of natural killer cell function by flow cytometry.Expression of interleukin-15 and interleukin-15Rα in monocytes of HIV type 1-infected patients with different courses of disease progression.The use of interleukin-2 in human immunodeficiency virus infection.Thymosin increases production of T-cell growth factor by normal human peripheral blood lymphocytes.Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis.In vivo application of recombinant interleukin 2 in the immunotherapy of established cytomegalovirus infectionProlonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection.Recognition of virus-infected cells by natural killer cell clones is controlled by polymorphic target cell elements.Cytotoxic activity against maedi-visna virus-infected macrophagesDifferential replication of human immunodeficiency virus type 1 in CD8- and CD8+ subsets of natural killer cells: relationship to cytokine production pattern.Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infectionRegulation by recombinant interleukin-2 of protective immunity against recurrent herpes simplex virus type 2 genital infection in guinea pigs.Effects of cyclosporine in experimental cryptococcal meningitis.Association of alpha interferon production with natural killer cell lysis of U937 cells infected with human immunodeficiency virusActivation of antigen-induced lymphocyte proliferation by interleukin-15 without the mitogenic effect of interleukin-2 that may induce human immunodeficiency virus-1 expression.Natural killer cells: versatile roles in autoimmune and infectious diseases.AIDS and autoimmunity.
P2860
Q33458677-121D8211-6DAF-41E1-BE61-73828980B8FBQ33606519-8BFC6580-BDE6-4ABD-94F2-0AF74F6AC848Q33847612-FF6137D8-6234-4549-842F-DE4F974A856FQ33863961-F2272CF2-B95C-474B-9980-780A83F2263BQ34020126-F12EF7DD-283D-412E-82C1-60F9A62EDDC5Q34164731-BAAA7FCA-00B0-466A-914F-06C73FBD6563Q34195088-A1007FCF-D71B-4E94-A6CB-A9CE9949752DQ34275424-3C822E04-6C45-4545-BFE3-B1CE8BEEC869Q34301399-95A8FBA9-A857-45CA-9002-8478225A321BQ34521424-22FED7F5-83A7-4360-8AC0-1A2C6BADDD46Q34562317-E30FB9BB-6FAF-4773-B282-E3AC0CFAD605Q34565648-80CF0AE5-69ED-44AC-8EBD-E3EA1CC8C223Q34572991-3AB87110-25FD-4A99-A3E4-F3E8BCAE36B0Q34581195-DE84A6AC-1CD6-4543-A6E5-9C62CED75467Q34614312-DE035AF3-CC1A-42D5-A0A6-22D4ACB529EEQ34619968-09AB4265-EF6E-4F59-915A-7499C684CAC3Q34622269-6292B246-619F-4854-ABDE-5DE06C2AD547Q34622519-AA25C2A4-6736-4988-901A-CAEA8CF6072CQ34627351-0CBF1827-70D2-4050-BD30-C291108A6889Q34630635-B13626AD-6719-4DCB-A6F6-51AFAA7451D1Q34660778-058E0DEC-46C8-4890-911D-B69B7920E08EQ34743805-E7469D7C-1156-4C7E-990C-77CDE75D3591Q35121891-08D85215-CC7E-4F47-B272-4117E3232B1FQ35226752-DED57A81-1C17-4167-B57A-CCDEF01EB87DQ36050117-EFD83B37-86CB-4119-B2CD-F4C98EB08AEFQ36070906-D75769A2-5011-4C74-9A01-21A3A116E425Q36259822-4373FEC2-961D-4F11-9676-588A3916D3ADQ36351819-EF06F869-70E0-4410-B23A-CBC36D55B4C7Q36352435-E449FF44-7D1C-47B1-B782-1E6E22F6ABCFQ36361254-75ECD4C9-5A09-4A10-9FB5-551D4F48495DQ36362289-1C5776E8-8293-4B2F-8EA1-38384B6236F7Q36638218-1035DC1D-DD98-4B7B-8DAA-FC0FE33CD501Q36653202-B06B5513-9A90-4EC5-A656-69CE8E7CB351Q36889122-EE5B208D-6EA3-4D2B-B664-80CAE7FDB77AQ36889622-7E36F0F9-76E4-44D8-892B-8C632AE05223Q37052552-2374131F-8C70-4F22-8079-842B242C937EQ37166999-22472F37-2A33-4B6B-BB1D-3BE34BD0BCC3Q37358046-322F714D-DB74-4AAD-8E00-49D3CB988701Q37754682-7DA4902F-4159-4B11-A5E8-8F79C13DBD13Q38219256-BF59ECED-6F42-45B1-8A57-3622983597A7
P2860
Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.
description
1983 nî lūn-bûn
@nan
1983 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
name
Interleukin-2 enhances the dep ...... ed immune deficiency syndrome.
@ast
Interleukin-2 enhances the dep ...... ed immune deficiency syndrome.
@en
type
label
Interleukin-2 enhances the dep ...... ed immune deficiency syndrome.
@ast
Interleukin-2 enhances the dep ...... ed immune deficiency syndrome.
@en
prefLabel
Interleukin-2 enhances the dep ...... ed immune deficiency syndrome.
@ast
Interleukin-2 enhances the dep ...... ed immune deficiency syndrome.
@en
P2093
P2860
P921
P356
P1476
Interleukin-2 enhances the dep ...... ed immune deficiency syndrome.
@en
P2093
Frederick W
Kasahara T
Manischewitz JF
Quinnan GV Jr
P2860
P304
P356
10.1172/JCI110981
P407
P577
1983-07-01T00:00:00Z